“Focusing on IL-6/STAT3 Pathway shows the approach of anti-IL-6 antibody (tocilizumab) in the treatment of multiple hydrocephalus”, Current Opinion, vol. 1, no. 01, pp. 15–19, Dec. 2021, Accessed: Jan. 23, 2025. [Online]. Available: https://currentopinion.info/index.php/co/article/view/14